Research Paper Volume 16, Issue 1 pp 348—366
SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis
Figure 8. SNRPB knockdown combined with sorafenib treatment inhibits tumor growth in vivo. (A) Tumor volume curves differences of each nude mouse xenograft model (Lv-shNC, Lv-shNC+Sorafenib, Lv-shSNRPB2, and Lv-shSNRPB2+Sorafenib). (B, C) Tumor size and weight differences of each nude mouse xenograft model. (D, E) The IHC staining and HE staining analysis the expression levels of SNRPB and SLC7A11 in the xenograft tumors.